Pascual-Castroviejo syndrome type 1
Other namesCerebrofaciothoracic dysplasia
Autosomal recessive pattern is the inheritance manner of this condition.
CausesMutations in the TMCO1 gene

Pascual-Castroviejo syndrome type 1 is a rare autosomal recessive condition characterized by facial dysmorphism, cognitive impairment and skeletal anomalies.[1]

Signs and symptoms

These can be divided into four areas[2]

Genetics

This disease is caused by mutations in the transmembrane and coiled-coil domain-containing protein 1 (TMCO1) on the long arm of chromosome 1.[3]

Diagnosis

The diagnosis may be provisionally made on clinical grounds. Further diagnostic tests include serum and urine analysis for lactic acid, a chest X-ray (or cardiac CT or MRI) and echocardiography. Biopsies from cardiac and skeletal muscle will show the presence of lipid and glycogen. Testing for mitochondrial abnormalities including adenosine nucleotide transporter deficiency and decreases in the respiratory chain complexes I and IV can also be done.

Differential diagnosis

Coffin syndrome must also be considered due to the facial appearance, which includes a large forehead, hypertelorism, and some degree of micrognathia. Coffin syndrome patients have vertebral anomalies that contribute to kyphosis, but no rib deformities have been described, and facial dysmorphic traits are more evident. Similar dysmorphic traits have been described in Robinow syndrome, albeit many features, such as normal genitalia, mental impairment, and a lack of limb bone deformities, are discordant.[4]

Treatment

There is no known treatment for this condition. Surgery may be helpful in treating the cleft lip and palate.

Prognosis

All cases to date have been reported in children. Long term prognosis is not known.

Epidemiology

Pascual-Castroviejo syndrome type 1 is rare. About 20 cases have been reported worldwide.

History

This condition was first described in 1975.[5]

References

  1. ↑ "Orphanet: Cerebrofaciothoracic dysplasia". Orphanet. October 23, 2023. Retrieved October 24, 2023.
  2. ↑ Alanay, Yasemin; Ergüner, Bekir; Utine, Eda; Haçarız, Orçun; Kiper, Pelin Ozlem Simsek; Taşkıran, Ekim Zihni; Perçin, Ferda; Uz, Elif; Sağıroğlu, Mahmut Şamil; Yuksel, Bayram; Boduroglu, Koray; Akarsu, Nurten Ayse (November 5, 2013). "TMCO1 deficiency causes autosomal recessive cerebrofaciothoracic dysplasia". American Journal of Medical Genetics Part A. Wiley. 164 (2): 291–304. doi:10.1002/ajmg.a.36248. ISSN 1552-4825.
  3. ↑ Pehlivan, Davut; Karaca, Ender; Aydin, Hatip; Beck, Christine R; Gambin, Tomasz; Muzny, Donna M; Bilge Geckinli, B; Karaman, Ali; Jhangiani, Shalini N; Gibbs, Richard A; Lupski, James R (January 15, 2014). "Whole-exome sequencing links TMCO1 defect syndrome with cerebro-facio-thoracic dysplasia". European Journal of Human Genetics. Springer Science and Business Media LLC. 22 (9): 1145–1148. doi:10.1038/ejhg.2013.291. ISSN 1018-4813. PMC 4135405.
  4. ↑ Rufo-Campos, Miguel; Riveros-Huckstadt, Pilar; RodrÍguez-Criado, Germán; Hernández-Soto, RocÍo (2004). "Another case of cerebro-facio-thoracic dysplasia (Pascual-Castroviejo syndrome)". Brain and Development. Elsevier BV. 26 (3): 209–212. doi:10.1016/s0387-7604(03)00133-5. ISSN 0387-7604.
  5. ↑ Pascual-Castroviejo I, Santolaya JM, Martin VL, Rodriguez-Costa T, Tendero A and Mulas F (1975) Cerebro-facio-thoracic dysplasia: Report of three cases. Dev Med Child Neurol 17:343–351
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.